112 results on '"Bortoluzzi I"'
Search Results
2. The role of hepatitis C virus eradication with DAA on insulin resistence regulation
3. Insulin resistance improvement after effective Hepatitis C virus eradication and its role on the onset of complications of advanced liver disease
4. SPONTANEOUS BACTERIAL PERITONITIS (SBP) IS NOT ASSOCIATED WITH HIGHER MORTALITY IF COMPARED WITH OTHER INFECTIONS IN PATIENTS AWAITING LIVER TRANSPLANTATION (LT)
5. CIRCULATING MICROPARTICLES AND RISK OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
6. WHOLE BLOOD COAGULATION TESTS ARE NOT EQUALLY ABLE TO DETECT HAEMOSTATIC PROTHROMBOTIC ALTERATIONS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA: ROTATIONAL THROMBOELASTOMETRY VERSUS THROMBINGENERATION TEST
7. P.06.18: Role of Sharkscore Needle Biopsy in EUS-Endoscopy: Is a Single Pass Enough?
8. OC.13.1: Eradication of HCV in Patients Awaiting Liver Transplantation does not Increase Drop-Out Due to HCC Progression
9. Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression
10. Characterisation of the immune response in patients with drug induced liver injury
11. Prothrombotic microparticles and risk of portal vein thrombosis in patients with HCV-related liver cirrhosis who underwent DAA antiviral therapy
12. Decreased hypercoagulable state in hepatitis C virus-cirrhotic patients treated with DAA: the outcome revolution
13. Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation
14. Whole blood coagulation tests are not equally able to detect haemostatic prothrombotic alterations in patients with liver cirrhosis and hepatocellular carcinoma (HCC): rotational thromboelastometry versus thrombingeneration test
15. Prevalence and risk factors of metabolic syndrome after liver transplantation: a single centre experience
16. EFFECTS OF NON-SELECTIVE beta-BLOCKERS ON HEMODYNAMICS AFTER LARGE VOLUME PARACENTESIS IN PATIENTS WITH CIRRHOSIS LISTED FOR LIVER TRANSPLANTATION: A PRELIMINARY REPORT
17. Effects of Non-Selective beta-Blockers on Hemodynamics and Paracentesis Induced Circulatory Dysfunction in Patients with Cirrhosis Undergoing Large Volume Paracentesis: a Preliminary Report
18. HCV eradication is not associated with drop-out due to HCC progression in patients awaiting liver transplantation: A monocentric experience
19. OC.03.9 SPONTANEOUS BACTERIAL PERITONITIS (SBP) IS NOT ASSOCIATED WITH HIGHER MORTALITY IF COMPARED WITH OTHER INFECTIONS IN PATIENTS AWAITING LIVER TRANSPLANTATION (LT)
20. Peripheral NK cells in patients with HCV recurrence after liver transplantation during interferon-free antiviral therapy
21. Circulating microparticles and risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma
22. OC.03.7 CIRCULATING MICROPARTICLES AND RISK OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
23. P.10.8 PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE
24. Presentation and outcome in patients with drug induced liver injury: A three-year experience
25. Transition of pediatric liver transplanted recipients to Adult Healthcare Service: A single center cohort
26. Whole Blood Coagulation Tests are not Equally able to Detect Haemostatic Prothrombotic Alterations in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Rotational Thromboelastometry versus Thrombingeneration Test
27. FRI-382 - The role of hepatitis C virus eradication with DAA on insulin resistence regulation
28. RUOLO PREDITTIVO DELL’ALFAFETOPROTEINA (AFP) SULLA SOPRAVVIVENZA DEI PAZIENTI AFFETTI DA EPATOCARCINOMA (HCC)
29. Incidence of De Novo Tumors after Liver Transplantation: Results from a Multicentric Study, Italy 1990-2009
30. P0074 : Prevalence and risk factors of metabolic syndrome after liver transplantation: a single centre experience
31. PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE
32. P931 EFFECTS OF NON-SELECTIVE β-BLOCKERS (NSBB) ON HEMODYNAMICS AND PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION IN CIRRHOTIC PATIENTS UNDERGOING LARGE VOLUME PARACENTESIS (LVP)
33. P930 BLEEDING-UNRELATED MORTALITY IS NOT INCREASED IN PATIENTS WITH CIRRHOSIS AND ASCITES ON TREATMENT WITH β-BLOCKERS: A META-ANALYSIS
34. OC.19.2 BLEEDING-UNRELATED MORTALITY IS NOT INCREASED IN PATIENTS WITH CIRRHOSIS AND ASCITES ON TREATMENT WITH β-BLOCKERS: A META-ANALYSIS
35. Italian survey on HBV and liver transplantation in a cohort of 2260 patients
36. Bleeding-unrelated mortality is not increased in patients with cirrhosis and ascites on treatment with β-blockers: A meta-analysis
37. FRI-435 - Transition of Pediatric Liver Transplanted Recipients to Adult Healthcare Service: A Single Center Cohort
38. THU-004 - Whole Blood Coagulation Tests are not Equally able to Detect Haemostatic Prothrombotic Alterations in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Rotational Thromboelastometry versus Thrombingeneration Test
39. THU-003 - Circulating Microparticles and Risk of Portal Vein Thrombosis in Patients with Liver Cirrhosis and Hepatocellular Carcinoma
40. Use of Grafts From Anti-HBc–Positive Donors in Liver Transplantation: A 5-Year, Single-Center Experience
41. 235 PREDICTORS OF RESPONSE TO ANTICOAGULANT THERAPY FOR THE TREATMENT OF PORTAL VEIN THROMBOSIS (PVT) IN CIRRHOSIS PATIENTS
42. 141 USE OF ANTI-HBc POSITIVE DONORS IN LIVER TRANSPLANTATION: THE EXPERIENCE OF PADUA LIVER TRANSPLANT CENTRE
43. F-48 Liver transplantation for HBV-related liver disease: the experience of Padua Liver Transplant Center
44. F-33 Predictors of response to anticoagulant therapy for the treatment of portal vein thrombosis (PVT) in cirrhosis patients
45. P1111 EFFECTIVENESS OF WEEKLY ORAL IRON SUPPLEMENTATION IN INCREASING HEMOGLOBIN LEVEL IN TERENA INDIAN CHILDREN FROM MATO GROSSO DO SUL, BRAZIL
46. P.16.10 EFFECTS OF NON SELECTIVE β-BLOCKERS (NSBB) ON HEMODYNAMICS AND PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION IN CIRRHOTIC PATIENTS UNDERGOING LARGE VOLUME PARACENTESIS (LVP)
47. Effects of Non-Selective β-Blockers on hemodynamic and Paracentesis Induced Circulatory Dysfunction in cirrhotics undergoing large volume paracentesis
48. Italian survey on HBV and liver transplantation in a cohort of 2260 patients
49. 235 PREDICTORS OF RESPONSE TO ANTICOAGULANT THERAPY FOR THE TREATMENT OF PORTAL VEIN THROMBOSIS (PVT) IN CIRRHOSIS PATIENTS.
50. Hepatitis C virus eradication with direct-acting antiviral improves insulin resistance.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.